ARTICLE | Distillery Therapeutics
Autoimmune disease; neurology
October 25, 2018 5:58 PM UTC
Mouse studies suggest a mAb against fibrin could help treat MS and AD. In a mouse model of chronic MS and two mouse models of relapsing-remitting MS (RRMS), a mAb targeting fibrin decreased paralysis ...
BCIQ Company Profiles
BCIQ Target Profiles